Results from the systematic review and meta-analysis demonstrated the positive effect of DAA therapy on overall survival, HCC-free survival, and liver function among patients with HCV decompensated cirrhosis compared to a non-DAA control group.
About half of actively drinking patients hospitalized for alcohol-associated hepatitis or decompensated alcohol-related cirrhosis undergo an intervention that can improve outcomes.
The 10 best-selling liver health supplements on Amazon bring in an estimated $2.5 million each month. But none of them contain ingredients recommended by doctors who treat liver issues.